A Phase 1 Protocol of 5-Azacytidine and Erlotinib in Advanced Solid Tumor Malignancies

NCT00996515 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Advanced Solid Tumor Malignancies

Interventions

DRUG: 5-azacytidine, erlotinib
DRUG: Erlotinib PO and Vidaza IV

Sponsor

New Mexico Cancer Research Alliance